Population-based screening for the prevention of lower extremity complications in diabetes

Diabetes/Metabolism Research and Reviews

Volumn 29, Issue 3, 2013, Pages 173-182

  Ozdemir, B A ^a   Brownrigg, J ^a   Patel, N ^a   Jones, K G ^a   Thompson, M M ^a   Hinchliffe, R J ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amputation; Diabetes; Diabetic foot; Risk stratification; Screening

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; FOLLOW UP; FOOT AMPUTATION; FOOT CARE; HIGH RISK PATIENT; HUMAN; MASS SCREENING; PATIENT EDUCATION; PATIENT REFERRAL; POPULATION BASED SCREENING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SECONDARY HEALTH CARE;

AMPUTATION; COST-BENEFIT ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; HUMANS; MASS SCREENING; RISK FACTORS;

EID: 84875022280     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2383     Document Type: Review

References (33)

1. Houtum WH, Lavery LA, Harkless LB. The costs of diabetes-related lower extremity amputations in the Netherlands. Diabet. Med. 1995; 12(9): 777-781.
2. The NHS Information Centre. National Diabetes Audit Executive Summary. 2011.
3. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011; 378(9785): 31-40.
4. Vamos EP, Bottle A, Edmonds ME, Valabhji J, Majeed A, Millett C. Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care 2010; 33(12): 2592-2597.
5. Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia 2012; 55(7): 1919-1925.
6. Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE study. Diabetologia 2008; 51(5): 747-755.
7. Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care 2007; 30(3): 660-663.
8. Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 2011; 54(5): 1190-1199.
9. National Institute of Clinical Excellence. Type 2 diabetes prevention and management of foot problems. 2004. Available from: www.nice.org.uk/CG010NICEguideline
10. Scottish Intercollegiate Guidelines Network 116. Management of diabetes. A national clinical guideline. 2010. Available from: http://www.sign.ac.uk/pdf/sign116.pdf
11. Executive summary: standards of medical care in diabetes-2012. Diabetes Care 2011; 35(Suppl 1): S4-10.
12. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev. 2000; 16(Suppl 1): S84-92.
13. Leese GP, Stang D, Pearson DW. A national approach to diabetes foot risk stratification and foot care. Scott. Med. J. 2011; 56(3): 151-155.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(6): e1000097.
15. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370(9596): 1453-1457.
17. Lincoln NB, Radford KA, Game FL, Jeffcoate WJ. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia 2008; 51(11): 1954-1961.
18. Litzelman DK, Slemenda CW, Langefield CD, et al. Reduction of lower extremity clinical abnormalities in patiens with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann. Intern. Med. 1993; 119(1): 36-41.
19. McCabe CJ, Stevenson RC, Dolan AM. Evaluation of a diabetic foot screening and protection programme. Diabet. Med. 1995; 15(1): 80-84.
20. McMurray SD, Johnson G, Davis S, McDougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit.Am. J. Kidney Dis. 2002; 40(3): 566-575.
21. Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes application of the staged diabetes management approach in a primary care setting. J. Fam. Pract. 1998; 47(2): 127-132.
22. Patout CA, Birke JA, Horswell R, Williams D, Cerise FP. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Diabetes Care 2000; 23(9): 1339-1342.
23. Anichini R, Zecchini F, Cerretini I, et al. Improvement of diabetic foot care after the implementation of the International Consensus on the Diabetic Foot (ICDF): results of a 5-year prospective study. Diabetes Res. Clin. Pract. 2007; 75(2): 153-158.
24. Lavery La, Wunderlich RP, Tredwell JL. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res. Clin. Pract. 2005; 70(1): 31-37.
25. Dorresteijn JAN, Kriegsman DMW, Valk GD. Complex interventions for preventing diabetic foot ulceration. Cochrane Database Syst. Rev. 2010; 20(1): CD007610. doi:10.1002/14651858.CD007610.pub2.
26. Mason J, O'Keeffe C, McIntosh a, Hutchinson a, Booth a, Young RJ. A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I: prevention. Diabet. Med. 1999; 16(10): 801-812.
27. Canavan R, Unwin N, Kelly W. Diabetes-and nondiabetes-related lower extremity amputation incidence before and after the introduction of better organized diabetes foot care. Diabetes Care 2008; 31(3): 459-463.
28. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006; 295(5): 536-546.
29. Leese GP, Stang D, Mcknight JA. A national strategic approach to diabetic foot disease in Scotland: changing a culture. Br J Diabetes Vasc Dis 2011; 11(2): 69-73.
30. Oretgon MM, Redekop WK, Niessen LW. Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis. Diabetes Care 2004; 27(4): 901-907.
31. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001; 44(11): 2077-2087.
32. Crawford F, Mccowan C, Dimitrov BD, et al. The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM 2011; 104(5): 403-410.
33. Dorresteijn JAN, Kriegsman DMW, Assendelft WJJ, Valk GD. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst. Rev. 2010; 12(5): CD001488. doi:10.1002/14651858.CD001488.pub3.